期刊
CUREUS JOURNAL OF MEDICAL SCIENCE
卷 12, 期 10, 页码 -出版社
SPRINGERNATURE
DOI: 10.7759/cureus.11150
关键词
hepatocellular carcinoma; liver transplantation; pd-1 inhibitor
The treatment of recurrent hepatocellular carcinoma (HCC) after liver transplantation is difficult due to the lack of effective treatment options. The available evidence on the emerging immunotherapy in liver transplantation is based on anecdotal experiences and requires additional investigations. To determine the efficacy and safety of immunotherapy in liver transplant recipients, we report three cases of recurrent metastatic HCC after liver transplantation who were treated with nivolumab as off-label salvage therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据